A Genomic “Roadmap” to “Better” Drugs

REFERENCES

• Baetz K., McHardy L., Gable K., Tarling T., RebÇrioux D., Bryan J., Andersen R.J., Dunn T., Hieter P., Roberge M. Yeast genome-wide drug-induced haploinsufficiency screen to determine drug mode of action. Proc Natl Acad Sci USA 2004; 101: 4525–4530
   PubMed Web of Science ®Google Scholar
• Bild A., Yao G., Chang J., Wang Q., Potti A., Chasse D., Joshi M., Harpole D., Lancaster J., Berchuck A., et al. Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature 2006; 439: 353–357
   PubMed Web of Science ®Google Scholar
• Brenner C. Chemical genomics in yeast. Genome Biol. 2004; 5: 240–244
   PubMedGoogle Scholar
• Carrasco D.R., Tonon G., Huang Y., Zhang Y., Sinha R., Feng B., Stewart J.P., Zhan F., Khatry D., Protopopova M. High-resolution genomic profiles define distinct clinico-pathogenetic subgroups of multiple myeloma patients. Cancer Cell 2006; 9: 313–325
   PubMed Web of Science ®Google Scholar
• Cervino A.C., Li G., Edwards S., Zhu J., Laurie C., Tokiwa G., Lum P.Y., Wang S., Castellini L.W., Lusis A.J., et al. Integrating QTL and high-density SNP analyses in mice to identify Insig2 as a susceptibility gene for plasma cholesterol levels. Genomics 2005; 86: 505–517
   PubMed Web of Science ®Google Scholar
• Chanock S. J., Manolio T., Boehnke M., Boerwinkle E., Hunter D. J., et al. Replicating genotype-phenotype associations. Nature 2007b; 447: 655–660
   PubMed Web of Science ®Google Scholar
• Clayton T., Lindon J., Cloarec O., Antti H., Charuel C., Hanton G., Provost J., Le N., Baker D., Walley R., et al. Pharmaco-metabonomic phenotyping and personalized drug treatment. Nature 2006; 440: 1073–1077
   PubMed Web of Science ®Google Scholar
• Drummelsmith J., Brochu V., Girard I., Messier N., Ouellette M. Proteome mapping of the protozoan parasite Leishmania and application to the study of drug targets and resistance mechanisms. Mol. Cell. Proteom. 2003; 2: 146–155
   PubMed Web of Science ®Google Scholar
• Drummelsmith J., Girard I., Trudel N., Ouellette M. Differential protein expression analysis of Leishmania major reveals novel roles for methionine adenosyltransferase and S-adenosylmethionine in methotrexate resistance. J. Biol. Chem. 2004; 279: 33273–33280
   PubMed Web of Science ®Google Scholar
• Easton D.F., Pooley K.A., Dunning A.M., Pharoah P.D.P., Thompson D., Ballinger D.G., Struewing J.P., Morrison J., Field H., Luben R., et al. Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 2007; 447: 1087–1093
   PubMed Web of Science ®Google Scholar
• Ewens A., Luo L., Berleth E., Alderfer J., Wollman R., Hafeez B., Kanter P., Mihich E., Ehrke M. Doxorubicin plus interleukin-2 chemoimmunotherapy against breast cancer in mice. Cancer Res. 2006; 66: 5419–5426
   PubMed Web of Science ®Google Scholar
• Fan C., Oh D.S., Wessels L., Weigelt B., Nuyten D.S.A., Nobel A.B., van't Veer L.J., Perou C.M. Concordance among gene-expression-based predictors for breast cancer. New Engl. J. Med. 2006; 355: 560–569
   PubMed Web of Science ®Google Scholar
• Feng B., Mills J., Mireles R., Janiszewsiki J., Troutman M., Morais S. In Vitro P-glyprotein assays to predict the clinical interactions of pglycoprotein with drugs in the central nervous system. Drug Metab. Dispos. 2007, In press
   Google Scholar
• Gagne J.F., Montminy V.B.P., Gaucher G., Guillemette C. Common Human UGT1A polymorphisms and the altered metabolism of irinotecan active metabolite 7-ethyl-10-hydroxycamptothecin (SN-38). Mol. Pharmacol. 2002; 62: 608–617
   PubMed Web of Science ®Google Scholar
• Galloway S.M. Cytotoxicity and chromosome aberrations in vitro: experience in industry and the case for an upper limit on toxicity in the aberration assay. Environ. Mol. Mutagen. 2000; 35: 191–201
   PubMed Web of Science ®Google Scholar
• Ganter B., Tugendreich S., Pearson C.I., Ayanoglu E., Baumhueter S., Bostian K.A., Brady L., Browne L.J., Calvin J.T., Day G.J. Development of a large-scale chemogenomics database to improve drug candidate selection and to understand mechanisms of chemical toxicity and action. J. Biotechnol. 2005; 119: 219–244
   PubMed Web of Science ®Google Scholar
• Guo Y., Shafer S., Weller P., Usuka J., Peltz G. Pharmacogenomics and drug development. Pharmacogenomics 2005; 6: 857–864
   PubMed Web of Science ®Google Scholar
• Guo Y.Y., Liu P., Zhang X., Weller P.M.M., Wang J., Liao G., Zhang Z., Hu J., Allard J., Shafer S., et al. In vitro and In silico Pharmacogenetic Analysis in Mice. Proc. Natl. Acad. Sci. 2007; 104: 17735–17740
   PubMed Web of Science ®Google Scholar
• Guo Y.Y., Weller P.F., Farrell E., Cheung P., Fitch B., Clark D., Wu S.Y., Wang J., Liao G., Zhang Z., et al. In Silico pharmacogenetics: Warfarin metabolism. Nature Biotechnol. 2006; 24: 531–536
   PubMed Web of Science ®Google Scholar
• Hakonarson H., Grant S.F.A., Bradfield J.P., Marchand L., Kim C.E., Glessner J.T., Grabs R., Casalunovo T., Taback S.P., Frackelton E.C., et al. A genome-wide association study identifies KIAA0350 as a type 1 diabetes gene. Nature 2007; 448: 591–594
   PubMed Web of Science ®Google Scholar
• Hastwell P.W., Chai L.L., Roberts K.J., Webster T.W., Harvey J.S., Rees R.W., Walmsley R.M. High-specificity and high-sensitivity genotoxicity assessment in a human cell line: Validation of the GreenScreen HC GADD45a-GFP genotoxicity assay. Mutat. Res. 2006; 607: 160–175
   PubMed Web of Science ®Google Scholar
• Hu T., Gibson D.P., Carr G.J., Torontali S.M., Jay P., Chaney J.G., Aardema M.J. Identification of a gene expression profile that discriminates indirect-acting genotoxins from direct-acting genotoxins. Mutation Research 2004; 549: 5–27
   PubMed Web of Science ®Google Scholar
• Hudis C.A. Trastuzumab—Mechanism of action and use in clinical practice. New Engl. J. Med. 2007; 357: 39–51
   PubMed Web of Science ®Google Scholar
• Isidori A., Giannetta E., Gianfrilli D., Greco E., Bonifacio V., Aversa A., Isidori A., Fabbri A., Lenzi A. Effects of testosterone on sexual function in men: results of a meta-analysis. Clin. Endocrinol. 2005; 63: 381–394
   PubMed Web of Science ®Google Scholar
• Kirkland D., Aardema M., Henderson L., Muller L. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I, Sensitivity, specificity and relative predictivity. Mutat. Res. 2005; 584: 1–256
   PubMed Web of Science ®Google Scholar
• Kleno T.G., Kiehr B., Baunsgaard D., Sidelmann U.G. Combination of ‘omics’ data to investigate the mechanisms of hydrazine-induced hepatotoxicity in rats and to identify potential biomarkers. Biomarkers 2004; 9: 116–138
   PubMed Web of Science ®Google Scholar
• Levitt S.D., Dubner S.J. Freakonomics. Harper Collins Publishers Inc, New York City 2005
   Google Scholar
• Liang D., Liao G., Wang J., Usuka J., Guo Y.Y., Peltz G., Clark J.D. A genetic analysis of opioid-induced hyperalgesia in mice. Anesthesiology 2006a; 104: 1054–1062
   PubMed Web of Science ®Google Scholar
• Liang D.Y., Liao G., Lighthall G., Peltz G., Clark J.D. Genetic variants of the P-glycoprotein gene Abcb1b modulate opioid-induced hyperalgesia, tolerance and dependence. Pharmacogen. Genomics 2006b; 16: 825–835
   PubMed Web of Science ®Google Scholar
• Liao G., Wang J., Guo J., Allard J., Chang J., Nguyen A., Shafer S., Puech A., McPherson J.D., Foernzler D., et al. In Silico genetics: Identification of a novel functional element regulating H2-Ea gene expression. Science 2004; 306: 690–695
   PubMed Web of Science ®Google Scholar
• Lu P., Ragnan A., Chan S.Y., Appling D.R., Hoffman D.W., Marcotte E.M. Global metabolic changes following loss of a feedback loop reveal dynamic steady states of the yeast metabolome. Metabolic Eng. 2007; 9: 8–20
   PubMed Web of Science ®Google Scholar
• Lum P., Armour C., Stepaniants S., Cavet G., Wolf M., Butler J., Hinshaw J., Garnier P., Prestwich G., Leonardson A., et al. Discovering modes of action for therapeutic compounds using a genome-wide screen of yeast heterozygotes. Cell 2004; 116: 121–137
   PubMed Web of Science ®Google Scholar
• Moffatt M.F., Kabesch M., Liang L., Dixon A.L., Strachan D., Heath S., Depner M., von Berg A., Bufe A., Rietschel E., et al. Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthma. Nature 2007; 448: 470–473
   PubMed Web of Science ®Google Scholar
• Nagar S., Blanchard R.L. Pharmacogenetics of Uridine Diphosphoglucuronosyltransferase (UGT) 1A family members and its role in patient response to irinotecan. Drug Metab. Rev. 2006; 38: 393–409
   PubMed Web of Science ®Google Scholar
• Newton R.K., Aardema M., Aubrecht J. The utility of DNA microarrays for characterizing genotoxicity. Environ. Health Perspect. 2004; 112: 420–422
   PubMed Web of Science ®Google Scholar
• Noshiro M., Lakso M., Kawajiri K., Negishi M. Rip locus: regulation of female-specific isozyme I-P-45016 alpha of testosterone 16 alpha-hydroxylase in mouse liver, chromosome localization, and cloning of P-450 cDNA. Biochemistry 1988; 27: 6434–6443
   PubMed Web of Science ®Google Scholar
• Noshiro M., Negishi M. Genetic regulation of estrogen-dependent repression of female-specific testosterone 16 alpha-hydroxylase I-P-45016 alpha in male mouse liver: murine Ripr locus. Biochemistry 1988; 27: 6444–6448
   PubMed Web of Science ®Google Scholar
• Parsons A.B., Lopez A., Givoni I.E., Williams D.E., Gray C.A., Porter J., Chua G., Sopko R., Brost R.L., Ho C.H. Exploring the mode-of-action of bioactive compounds by chemical-genetic profiling in yeast. Cell 2006; 126: 611–625
   PubMed Web of Science ®Google Scholar
• Pickering L.A., Branca M.A. Pharmaceutical industry dynamics has genomics failed to deliver?. Decision Resources, Inc., Boston, MA 2006; 1–29, In D
   Google Scholar
• Potti A., Mukherjee S., Petersen R., Dressman H.K., Bild A., Koontz J., Kratzke R., Watson M.A., Kelley M., Ginsburg G.S., et al. A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer. New Engl. J. Med. 2006; 355: 570–580
   PubMed Web of Science ®Google Scholar
• Solit D., Garraway L., Pratilas C., Sawai A., Getz G., Basso A., Ye Q., Lobo J., She Y., Osman I., et al. BRAF mutation predicts sensitivity to MEK inhibition. Nature 2006; 439: 358–362
   PubMed Web of Science ®Google Scholar
• Steiner G., Suter L., Boess F., Gasser R., de V., Albertini S., Ruepp S. Discriminating different classes of toxicants by transcript profiling. Environ. Health Perspect. 2004; 112: 1236–1248
   PubMed Web of Science ®Google Scholar
• van D., van A., van B., Herwijnen M.H., Staal Y., Kleinjans J.C.S. Discrimination of genotoxic from non-genotoxic carcinogens by gene expression profiling. Carcinogenesis 2004; 25: 1265–1276
   PubMed Web of Science ®Google Scholar
• von der H.W., Kalweit S., Engelhardt G., McKiernan S., Kasper P., Slacik E.R., Miltenburger H.G., Honarvar N., Fahrig R., Gîrlitz B., et al. In vitro micronucleus assay with Chinese hamster V79 cells—results of a collaborative study with in situ exposure to 26 chemical substances. Mutat. Res. 2000; 468: 137–163
   PubMed Web of Science ®Google Scholar
• Walmsley R.M. Genotoxicity screening: the slow march to the future. Expert Opin. Drug Metab. Toxicol. 2005; 1: 261–268
   PubMedGoogle Scholar
• Wang J., Liao G., Chang J., Nguyen A., Guo J., Chou S., Hu S., Bach C., Allard J., Shafer S., et al. Haplotypic structure of the mouse genome. Computational Genetics and Genomics: New Tools for Understanding Disease. Humana Press Inc., Totowa, New Jersey 2005a; 71–83
   Google Scholar
• Wang J., Liao G., Usuka J., Peltz G. Computational Genetics: From Mouse to Man?. Trends Genetics 2005b; 21: 526–532
   PubMed Web of Science ®Google Scholar
• Wang J., Peltz G. Haplotype-based computational genetic analysis in mice. Computational Genetics and Genomics: New Tools for Understanding Disease. Humana Press Inc, Totowa, New Jersey 2005; 51–70
   Google Scholar
• The Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007a; 447: 661–678
   PubMed Web of Science ®Google Scholar
• Yamazaki M., Neway W.E., Ohe T., Chen I.W., Rowe J.F., Hochman J.H., Chiba M., Lin J.H. In vitro substrate identification studies for p-glycoprotein-mediated transport: Species difference and predictability of in vivo results. J. Pharmacol. Exper. Therapeut. 2001; 296: 723–735
   PubMed Web of Science ®Google Scholar
• Yu J., Pressoir G., Briggs W.H., Vroh Bi I., Yamasaki M., Doebley J.F., McMullen M.D., Gaut B.S., Nielsen D.M., Holland J.B., et al. A unified mixed-model method for association mapping that accounts for multiple levels of relatedness. Nat. Genet. 2006; 38: 203–208
   PubMed Web of Science ®Google Scholar
• Zheng M., Lu P., Pease J., Liao G., Peltz G. An automated method for analysis of 2-dimensional 1H 13C NMR Spectra. Bioinformatics 2007; 21: 2926–2933
   Google Scholar